{"transactions":[{"id":743105,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":743104,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":643,"price":249,"value":160107.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $245.17 and $253.04."}],"balance_after":30389,"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":743103,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":31032,"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":744600,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:18:39.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526264041/ownership.xml","form_type":"4"}},{"id":754750,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":5537,"price":223.39,"value":1236910.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $221.82 and $225.21."}],"balance_after":29603,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":754749,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":230.3,"value":1381800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $229.56 and $232.14."}],"balance_after":35140,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":754748,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":233.46,"value":1400760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $231.50 and $235.23."}],"balance_after":41140,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":877263,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-28T00:00:07.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":161.11,"value":4027750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.33 and $162.26."}],"balance_after":47140,"source":{"system":"sec-edgar","filing":"0001193125-26-083587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526083587/ownership.xml","form_type":"4"}},{"id":881979,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-26T00:00:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":7721,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-072481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526072481/ownership.xml","form_type":"4"}},{"id":881978,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T00:00:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":4.95,"value":30937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":72140,"source":{"system":"sec-edgar","filing":"0001193125-26-072481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526072481/ownership.xml","form_type":"4"}},{"id":888083,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-24T00:23:38.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":12485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":13971,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":12485},"source":{"system":"sec-edgar","filing":"0001193125-26-064681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526064681/ownership.xml","form_type":"4"}},{"id":888082,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T00:23:38.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":12485,"price":4.95,"value":61800.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":65890,"source":{"system":"sec-edgar","filing":"0001193125-26-064681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526064681/ownership.xml","form_type":"4"}},{"id":911921,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-11T00:11:27.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":5193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":0,"derivative":{"exercise_price":8.02,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":5193},"source":{"system":"sec-edgar","filing":"0001193125-26-045110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526045110/ownership.xml","form_type":"4"}},{"id":911920,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T00:11:27.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":5193,"price":8.02,"value":41647.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":53405,"source":{"system":"sec-edgar","filing":"0001193125-26-045110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526045110/ownership.xml","form_type":"4"}},{"id":1044765,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-10T00:11:58.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":488,"price":127.4,"value":62171.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the open market purchase of shares of the Issuer's common stock."}],"balance_after":48212,"source":{"system":"sec-edgar","filing":"0000950170-25-113874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025113874/ownership.xml","form_type":"4"}},{"id":1044764,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-10T00:11:58.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":287,"price":127.3,"value":36535.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the open market purchase of shares of the Issuer's common stock."}],"balance_after":47724,"source":{"system":"sec-edgar","filing":"0000950170-25-113874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025113874/ownership.xml","form_type":"4"}},{"id":1044763,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-10T00:11:58.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":127.2,"value":101760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the open market purchase of shares of the Issuer's common stock."}],"balance_after":47437,"source":{"system":"sec-edgar","filing":"0000950170-25-113874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025113874/ownership.xml","form_type":"4"}},{"id":1116317,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-10T23:00:20.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026."}],"balance_after":1429,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0000950170-25-084560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025084560/ownership.xml","form_type":"4"}},{"id":1116316,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T23:00:20.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":3166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on the one-year anniversary of the date of grant, June 6, 2026."}],"balance_after":3166,"derivative":{"exercise_price":111.91,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":3166},"source":{"system":"sec-edgar","filing":"0000950170-25-084560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025084560/ownership.xml","form_type":"4"}},{"id":1130536,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-29T23:00:05.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":3750,"price":103.43,"value":387862.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $102.71 and $104.38."}],"balance_after":46637,"source":{"system":"sec-edgar","filing":"0000950170-25-079229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025079229/ownership.xml","form_type":"4"}},{"id":1130535,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-29T23:00:05.000Z","date":"2025-05-27","kind":"sale","planned":true,"acquired":false,"shares":3750,"price":105.47,"value":395512.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $104.75 and $106.50."}],"balance_after":50387,"source":{"system":"sec-edgar","filing":"0000950170-25-079229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025079229/ownership.xml","form_type":"4"}},{"id":1140427,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T01:46:49.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":107.491,"value":322473.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65."}],"balance_after":54137,"source":{"system":"sec-edgar","filing":"0000950170-25-075539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025075539/ownership.xml","form_type":"4"}},{"id":1310663,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T21:06:29.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":9127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options prior to expiration for cash and hold of underlying shares."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2016-11-19","expiration_date":"2025-11-19","underlying":"Common Stock","underlying_shares":9127},"source":{"system":"sec-edgar","filing":"0000950170-25-002052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025002052/ownership.xml","form_type":"4"}},{"id":1310662,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:06:29.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":9127,"price":9,"value":82143.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options prior to expiration for cash and hold of underlying shares."}],"balance_after":57137,"source":{"system":"sec-edgar","filing":"0000950170-25-002052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017025002052/ownership.xml","form_type":"4"}},{"id":1357225,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-20T21:30:41.000Z","date":"2024-11-19","kind":"exercise","planned":false,"acquired":false,"shares":33410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options prior to expiration for cash and hold of underlying shares."}],"balance_after":0,"derivative":{"exercise_price":5.94,"exercise_date":"2015-06-29","expiration_date":"2025-06-29","underlying":"Common Stock","underlying_shares":33410},"source":{"system":"sec-edgar","filing":"0000950170-24-129330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017024129330/ownership.xml","form_type":"4"}},{"id":1357224,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:30:41.000Z","date":"2024-11-19","kind":"exercise","planned":false,"acquired":true,"shares":33410,"price":5.94,"value":198455.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options prior to expiration for cash and hold of underlying shares."}],"balance_after":48010,"source":{"system":"sec-edgar","filing":"0000950170-24-129330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017024129330/ownership.xml","form_type":"4"}},{"id":1483436,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:31:50.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":5799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on the one-year anniversary of the date of grant, June 7, 2025."}],"balance_after":5799,"derivative":{"exercise_price":73.9,"exercise_date":"2025-06-07","expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":5799},"source":{"system":"sec-edgar","filing":"0000950170-24-071964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017024071964/ownership.xml","form_type":"4"}},{"id":1499139,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T00:11:32.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":5248,"price":75.1396,"value":394332.6208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90."}],"balance_after":14600,"source":{"system":"sec-edgar","filing":"0000950170-24-066175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017024066175/ownership.xml","form_type":"4"}},{"id":1499138,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T00:11:32.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":5249,"price":75.2095,"value":394774.6655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88."}],"balance_after":19848,"source":{"system":"sec-edgar","filing":"0000950170-24-066175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000095017024066175/ownership.xml","form_type":"4"}},{"id":1780121,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:30:32.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":false,"shares":11016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":3.67,"exercise_date":"2015-09-16","expiration_date":"2024-09-16","underlying":"Common Stock","underlying_shares":11016},"source":{"system":"sec-edgar","filing":"0001209191-23-049648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123049648/doc4.xml","form_type":"4"}},{"id":1780120,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:30:32.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":18572,"price":75.1771,"value":1396189.1012,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares."}],"balance_after":403856,"source":{"system":"sec-edgar","filing":"0001209191-23-049648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123049648/doc4.xml","form_type":"4"}},{"id":1780119,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:30:32.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":11016,"price":75.1853,"value":828241.2648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."}],"balance_after":25097,"source":{"system":"sec-edgar","filing":"0001209191-23-049648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123049648/doc4.xml","form_type":"4"}},{"id":1780118,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:30:32.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":true,"shares":11016,"price":3.67,"value":40428.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":36113,"source":{"system":"sec-edgar","filing":"0001209191-23-049648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123049648/doc4.xml","form_type":"4"}},{"id":1865177,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-06T22:21:51.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":5681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 2, 2024."}],"balance_after":5681,"derivative":{"exercise_price":74.12,"exercise_date":"2024-06-02","expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":5681},"source":{"system":"sec-edgar","filing":"0001209191-23-034847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123034847/doc4.xml","form_type":"4"}},{"id":1969100,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T23:13:39.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":2870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 2,870 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable."}],"balance_after":2870,"derivative":{"exercise_price":65.32,"exercise_date":"2023-03-02","expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":2870},"source":{"system":"sec-edgar","filing":"0001209191-23-016455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123016455/doc4.xml","form_type":"4"}},{"id":2067653,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:11:19.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":17501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options and hold of underlying shares."}],"balance_after":0,"derivative":{"exercise_price":1.3,"exercise_date":"2013-03-22","expiration_date":"2023-03-21","underlying":"Common Stock","underlying_shares":17501},"source":{"system":"sec-edgar","filing":"0001209191-23-000870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123000870/doc4.xml","form_type":"4"}},{"id":2067652,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:11:19.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":17501,"price":1.3,"value":22751.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options and hold of underlying shares."}],"balance_after":25097,"source":{"system":"sec-edgar","filing":"0001209191-23-000870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919123000870/doc4.xml","form_type":"4"}},{"id":2240160,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:07:10.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":16976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 3, 2023."}],"balance_after":16976,"derivative":{"exercise_price":25.53,"exercise_date":"2023-06-03","expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":16976},"source":{"system":"sec-edgar","filing":"0001209191-22-034820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919122034820/doc4.xml","form_type":"4"}},{"id":2327635,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-17T11:05:10.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":3496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options and hold of underlying shares."}],"balance_after":17501,"derivative":{"exercise_price":1.3,"exercise_date":"2013-03-22","expiration_date":"2023-03-21","underlying":"Common Stock","underlying_shares":3496},"source":{"system":"sec-edgar","filing":"0001209191-22-019403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919122019403/doc4.xml","form_type":"4"}},{"id":2327634,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T11:05:10.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":3496,"price":1.3,"value":4544.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options and hold of underlying shares."}],"balance_after":7596,"source":{"system":"sec-edgar","filing":"0001209191-22-019403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919122019403/doc4.xml","form_type":"4"}},{"id":2344459,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T22:00:40.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":2798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 2,798 options elected to be received in lieu of cash compensation earned in 2021. All of such options are immediately exercisable."}],"balance_after":2798,"derivative":{"exercise_price":29.91,"exercise_date":"2022-03-04","expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":2798},"source":{"system":"sec-edgar","filing":"0001209191-22-017156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919122017156/doc4.xml","form_type":"4"}},{"id":2500787,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T12:30:39.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":1021,"price":35.1,"value":35837.1,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares."}],"balance_after":422428,"source":{"system":"sec-edgar","filing":"0001209191-21-066004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919121066004/doc4.xml","form_type":"4"}},{"id":2500786,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T12:30:39.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":409,"price":35.07,"value":14343.63,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares."}],"balance_after":421407,"source":{"system":"sec-edgar","filing":"0001209191-21-066004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919121066004/doc4.xml","form_type":"4"}},{"id":2677589,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:51:49.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":7325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 4, 2022."}],"balance_after":7325,"derivative":{"exercise_price":61.32,"exercise_date":"2022-06-04","expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":7325},"source":{"system":"sec-edgar","filing":"0001209191-21-038952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919121038952/doc4.xml","form_type":"4"}},{"id":2714489,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T11:05:12.000Z","date":"2021-05-12","kind":"purchase","acquired":true,"shares":500,"price":58.15,"value":29075.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares."}],"balance_after":420998,"source":{"system":"sec-edgar","filing":"0001209191-21-032250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000120919121032250/doc4.xml","form_type":"4"}},{"id":2799983,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T02:45:30.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":1201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,201 options elected to be received in lieu of cash compensation earned in 2020. All of such options are immediately exercisable."}],"balance_after":1201,"derivative":{"exercise_price":65.02,"exercise_date":"2021-03-05","expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":1201},"source":{"system":"sec-edgar","filing":"0000899243-21-010805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000089924321010805/doc4.xml","form_type":"4"}},{"id":3051117,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T00:43:16.000Z","date":"2020-08-19","kind":"gift","acquired":true,"shares":397998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Whale Island, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred these shares to a family limited partnership, Whale Island LP, of which the reporting person is the sole general partner and of which the reporting person and his three children are the sole limited partners. Each of the reporting person's children have a 1% pecuniary interest in Whale Island LP.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":397998,"source":{"system":"sec-edgar","filing":"0001179110-20-009208","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911020009208/edgar.xml","form_type":"4"}},{"id":3051116,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T00:43:16.000Z","date":"2020-08-19","kind":"gift","acquired":false,"shares":397998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred these shares to a family limited partnership, Whale Island LP, of which the reporting person is the sole general partner and of which the reporting person and his three children are the sole limited partners. Each of the reporting person's children have a 1% pecuniary interest in Whale Island LP.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001179110-20-009208","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911020009208/edgar.xml","form_type":"4"}},{"id":3096615,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T12:20:25.000Z","date":"2020-06-29","kind":"purchase","acquired":true,"shares":650,"price":78.5,"value":51025.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"250,000 shares were previously transferred to the reporting person's former spouse for no consideration pursuant to a property settlement agreement entered into in connection with a divorce proceeding. The reporting person no longer reports as beneficially owned any securities owned by his former spouse."}],"balance_after":403698,"source":{"system":"sec-edgar","filing":"0001104659-20-078441","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465920078441/a4.xml","form_type":"4"}},{"id":3120425,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T22:40:36.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 5, 2021."}],"balance_after":13000,"derivative":{"exercise_price":77.38,"exercise_date":"2021-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001179110-20-007056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911020007056/edgar.xml","form_type":"4"}},{"id":3200763,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T01:17:51.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":3308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 3,308 options elected to be received in lieu of cash compensation earned in 2019. All of such options are immediately exercisable."}],"balance_after":3308,"derivative":{"exercise_price":45.14,"exercise_date":"2020-03-17","expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":3308},"source":{"system":"sec-edgar","filing":"0001179110-20-004007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911020004007/edgar.xml","form_type":"4"}},{"id":3476898,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-27T11:18:47.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":15800,"price":23.1,"value":364980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $22.90 to $23.25, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":668848,"source":{"system":"sec-edgar","filing":"0001179110-19-008149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911019008149/edgar.xml","form_type":"4"}},{"id":3476897,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-27T11:18:47.000Z","date":"2019-06-25","kind":"purchase","acquired":true,"shares":400,"price":23.25,"value":9300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $23.24 to $23.25, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":653048,"source":{"system":"sec-edgar","filing":"0001179110-19-008149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911019008149/edgar.xml","form_type":"4"}},{"id":3495755,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-10T22:20:59.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 7, 2020."}],"balance_after":13000,"derivative":{"exercise_price":22.03,"exercise_date":"2020-06-07","expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-19-034641","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465919034641/a4.xml","form_type":"4"}},{"id":3526072,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T11:21:44.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":4650,"price":21.44,"value":99696.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $21.42 to $21.49, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":652648,"source":{"system":"sec-edgar","filing":"0001179110-19-006055","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000117911019006055/edgar.xml","form_type":"4"}},{"id":3583028,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-21T20:06:28.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":25652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 25,652 options elected to be received in lieu of cash compensation earned in 2018. All of such options are immediately exercisable."}],"balance_after":25652,"derivative":{"exercise_price":12.95,"exercise_date":"2019-03-19","expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":25652},"source":{"system":"sec-edgar","filing":"0001104659-19-016569","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465919016569/a4.xml","form_type":"4"}},{"id":3583025,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-21T11:05:28.000Z","date":"2019-03-19","kind":"purchase","acquired":true,"shares":5100,"price":12.18,"value":62118.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $12.09 to $12.53, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001104659-19-016423","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465919016423/a4.xml","form_type":"4"}},{"id":3905510,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-06T00:21:41.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, June 1, 2019."}],"balance_after":13000,"derivative":{"exercise_price":3.45,"exercise_date":"2019-06-01","expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-18-038401","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465918038401/a4.xml","form_type":"4"}},{"id":3968490,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-05T14:05:33.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":27297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 27,297 options elected to be received in lieu of cash compensation earned in 2017.  All of such options are immediately exercisable."}],"balance_after":27297,"derivative":{"exercise_price":2.85,"exercise_date":"2018-03-12","expiration_date":"2028-03-11","underlying":"Common Stock","underlying_shares":27297},"source":{"system":"sec-edgar","filing":"0001104659-18-022602","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465918022602/a4.xml","form_type":"4"}},{"id":4380131,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-17T20:55:08.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the one-year anniversary of the date of grant, March 15, 2018."}],"balance_after":11000,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-17-017637","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465917017637/a4.xml","form_type":"4"}},{"id":4380130,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-17T20:55:08.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":26456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 11,000 options granted as compensation for service during 2016 and 15,456 options elected to be received in lieu of cash compensation earned in 2016.  All of such options are immediately exercisable."}],"balance_after":26456,"derivative":{"exercise_price":4.95,"exercise_date":"2017-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":26456},"source":{"system":"sec-edgar","filing":"0001104659-17-017637","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000110465917017637/a4.xml","form_type":"4"}}]}